Stochastic Pharmacokinetic/Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)
| dc.contributor.author | Convertino, Convertino | |
| dc.contributor.author | Church, Timothy | |
| dc.contributor.author | Olsen, Geary | |
| dc.contributor.author | Liu, Yang | |
| dc.contributor.author | Doyle, Eddie | |
| dc.contributor.author | Elcombe, Clifford | |
| dc.contributor.author | Barnett, Anna | |
| dc.contributor.author | Samuel, Leslie | |
| dc.contributor.author | MacPherson, Iain | |
| dc.contributor.author | Evans, Thomas | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.date.accessioned | 2018-11-09T12:10:05Z | |
| dc.date.available | 2018-11-09T12:10:05Z | |
| dc.date.issued | 2018-05-01 | |
| dc.description | This work was supported by the sponsor of this phase 1 clinical trial, CXR Biosciences (Dundee, UK). 3 M Company (St Paul, Minnesota) licensed a part of the database from CXR Biosciences for the purpose of the analyses presented herein. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 14 | |
| dc.format.extent | 998045 | |
| dc.identifier | 140499917 | |
| dc.identifier | d281d8eb-55ac-48ce-851a-887b193e69bb | |
| dc.identifier | 85046404402 | |
| dc.identifier.citation | Convertino, C, Church, T, Olsen, G, Liu, Y, Doyle, E, Elcombe, C, Barnett, A, Samuel, L, MacPherson, I & Evans, T 2018, 'Stochastic Pharmacokinetic/Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)', Toxicological Sciences, vol. 163, no. 1, pp. 293-306. https://doi.org/10.1093/toxsci/kfy035 | en |
| dc.identifier.doi | 10.1093/toxsci/kfy035 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 1096-6080 | |
| dc.identifier.other | ORCID: /0000-0002-8402-8670/work/50559783 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11415 | |
| dc.identifier.vol | 163 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Toxicological Sciences | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | APFO | en |
| dc.subject | phase 1 trial | en |
| dc.subject | PK/PD modeling | en |
| dc.subject | cholesterol | en |
| dc.subject | PFOA | en |
| dc.subject | thyroid | en |
| dc.subject | R Medicine | en |
| dc.subject | Pharmacology, Toxicology and Pharmaceutics(all) | en |
| dc.subject.lcc | R | en |
| dc.title | Stochastic Pharmacokinetic/Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA) | en |
| dc.type | Journal article | en |
